Healthspan Community Newsletter – October 15, 2026

Global Healthspan Policy Institute

This week we learn about new research suggesting that the ovaries may continue to play an important biological role after menopause, a potential connection between declining bone health and accelerated brain aging, and emerging discoveries that could reshape our understanding of healthy aging and age-related disease.

Edwina Rogers

Are you part of a health or life extension research organization? Our coalition has grown to over 90 member groups, including 25 major US organizations and 16 major international groups. We hope your organization will be next! Check below to find a link to join our coalition quickly and easily.

All this and more this week. Join us as we move forward into another exciting month of incredible opportunities in this burgeoning and revolutionary field.

Edwina Rogers, CEO
Global Healthspan Policy Institute

Ovaries illustration
Ovaries Develop an Intriguing Second Role After Menopause

Researchers examining ovarian tissue from postmenopausal women discovered that the ovaries remain biologically active, undergoing changes in metabolism, immune function, and inflammation that may influence aging and provide new insights into ovarian cancer risk. 

Read More

Hand X-ray
 

Weaker Bones Have Been Linked to Faster Brain Aging in a New Study

A new study from Johns Hopkins University found that lower bone mineral density was associated with changes in brain structure and faster cognitive decline, suggesting that bone health and brain aging may share underlying biological mechanisms.

Read More

Scientist using a microscope
Scientists discover how harmful “zombie cells” hide from the immune system

Scientists at Cedars-Sinai identified a protein called PD-L2 that helps senescent cells evade immune detection, with experiments in mice showing that blocking the protein reduced inflammation and improved metabolic function and physical strength, potentially opening new avenues for therapies targeting biological aging. 

Read More

Hand holding syringes
Could GLP-1 drugs be anti-aging medications?

Emerging research suggests that GLP-1 medications such as semaglutide and tirzepatide may influence biological aging beyond their established benefits for weight management and diabetes, although further studies are needed to determine whether these effects translate into longer, healthier lives. 

Read More

Copyright © 2026 Global Healthspan Policy Institute, All rights reserved.